Sanofi's Trading Details for March 2025
Sanofi is committed to ensuring transparency in all its operations. As of March 31, 2025, pertinent information regarding the total number of voting rights and shares has been disclosed in compliance with French commercial regulations. This data allows investors and stakeholders to stay informed about their investments and the governance of the company.
Key Financial Figures
Based on the latest filings, Sanofi has issued a total of 1,233,737,221 shares. The number of real voting rights available to shareholders stands at 1,351,370,330, which excludes any treasury shares. Additionally, the theoretical total of voting rights, including those treasury shares, reaches 1,366,610,643.
Understanding Voting Rights
The Importance of Voting Rights
Voting rights are significant for shareholders because they give them a say in crucial company decisions, such as electing board members and approving major changes. Understanding the dynamics of these rights can empower investors to make informed choices regarding their stockholdings.
How Treasury Shares Affect Voting
Treasury shares are those that a company holds in its own name, and they do not confer voting rights. While these shares are not counted in the total for shareholder voting, they can affect the overall value and voting power within the company. It’s essential for investors to grasp how these are managed and the potential impact on their rights and the company’s performance.
Investor Relations at Sanofi
Communication between Sanofi and its investors is vital for maintaining a healthy relationship and transparency. The Investor Relations Department is dedicated to providing timely and relevant information to shareholders. This ensures everyone has access to the necessary data for making informed decisions regarding their investments in Sanofi.
How to Contact Investor Relations
For inquiries or further information, investors can reach out to the Investor Relations Department via email at investor.relations@sanofi.com. This direct communication line helps facilitate better engagement and provides clarity on Sanofi's operations and strategies.
Staying Informed
To keep up with the latest updates and regulatory disclosures, interested parties are encouraged to visit Sanofi's official website section dedicated to regulated information. This resource serves as a hub for accessing essential company details and developments.
Frequently Asked Questions
What are voting rights and why are they important?
Voting rights allow shareholders to influence company decisions, making them crucial for any investor wishing to make an impact.
How many total shares does Sanofi have?
As of March 31, 2025, Sanofi has a total of 1,233,737,221 issued shares.
What is the difference between real and theoretical voting rights?
Real voting rights are counted without treasury shares, while theoretical voting rights include all shares, regardless of whether they are held as treasury shares.
How can investors contact Sanofi for information?
Investors can reach the Investor Relations Department through email at investor.relations@sanofi.com.
Where can I find more information on Sanofi?
Detailed information is available on Sanofi's website under their investor relations section, offering access to reports and news updates.
